American Diabetes Association Names Robert E. Ratner, MD, FACP, FACE as Organization's Chief Scientific and Medical Officer
(firmenpresse) - ALEXANDRIA, VA -- (Marketwire) -- 02/02/12 -- The American Diabetes Association announced today that Robert E. Ratner, MD, FACP, FACE has been named Chief Scientific and Medical Officer, effective May 7, 2012. Dr. Ratner is currently Professor of Medicine at Georgetown University Medical School and Senior Research Scientist at the MedStar Health Research Institute in metropolitan Washington, DC.
As Chief Scientific and Medical Officer for the American Diabetes Association, Dr. Ratner will serve as the primary medical and scientific representative and spokesperson for the Association's scientific and medical affairs, research program and other clinical activities, and oversee the planning, development, and implementation of a wide variety of strategic scientific and medical programs to support and advance the Association's mission.
"Bob Ratner is one of the brightest and most respected minds in diabetes," said Larry Hausner, Chief Executive Officer, American Diabetes Association. "He brings a remarkable breadth of experience to this vital role, and I am confident that his leadership and vision will be a strong guiding force in helping the Association achieve our strategic priorities and further our mission."
In addition to his roles at Georgetown and MedStar, Ratner is a Principle Investigator for the Diabetes Prevention Program (DPP) and DPP Outcomes Study of the National Institutes of Health (NIH), serving on the Steering Committee for the project nationwide. He currently serves as an Associate Editor of the Journal of Clinical Endocrinology and Metabolism and recently completed a sabbatical as a Robert Wood Johnson Foundation Health Policy Fellow, having served as the study director for the Institute of Medicine Comparative Effectiveness Research Priorities Committee, and a program examiner for health reform in the Health Division of the U.S. Office of Management and Budget.
Ratner received his medical degree from Baylor College of Medicine in Houston, Texas where he also completed his internal medicine training. He underwent fellowship training in endocrinology and metabolism at Harvard Medical School and the Joslin Diabetes Center in Boston. His research interests include diabetes therapeutics and complications, with an emphasis on translational efforts from controlled trials into community-based practice. He is the author of over 120 original scientific articles and 20 book chapters.
For the next three months, Dr. Ratner will be transitioning out of his current position, during which time Sue Kirkman, MD, Senior Vice President, Medical Affairs and Community Information, will be the Association's acting Chief Scientific and Medical Officer.
The American Diabetes Association is leading the fight to Stop Diabetes and its deadly consequences and fighting for those affected by diabetes. The Association funds research to prevent, cure and manage diabetes; delivers services to hundreds of communities; provides objective and credible information; and gives voice to those denied their rights because of diabetes. Founded in 1940, our mission is to prevent and cure diabetes and to improve the lives of all people affected by diabetes. For more information please call the American Diabetes Association at 1-800-DIABETES (1-800-342-2383) or visit . Information from both these sources is available in and .
Christine Feheley
703.253.4374
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 02.02.2012 - 11:15 Uhr
Sprache: Deutsch
News-ID 1079073
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
ALEXANDRIA, VA
Phone:
Kategorie:
Hospitals, Facilities and Providers
Anmerkungen:
Diese Pressemitteilung wurde bisher 154 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"American Diabetes Association Names Robert E. Ratner, MD, FACP, FACE as Organization's Chief Scientific and Medical Officer
"
steht unter der journalistisch-redaktionellen Verantwortung von
American Diabetes Association (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
